Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00482391
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2007-06-04
Brief Title:
Doxorubicin and Cyclophosphamide Followed by Paclitaxel Trastuzumab and Lapatinib in Treating Patients With HER2Neu-Overexpressed Breast Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Organization Data
Organization:
Memorial Sloan Kettering Cancer Center
Class:
OTHER
Study ID:
07-013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |
| National Cancer Institute NCI | NIH |
| Dana-Farber Cancer Institute | OTHER |